BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

767 related articles for article (PubMed ID: 18436088)

  • 1. Improving care of patients with diabetes and CKD: a pilot study for a cluster-randomized trial.
    Cortés-Sanabria L; Cabrera-Pivaral CE; Cueto-Manzano AM; Rojas-Campos E; Barragán G; Hernández-Anaya M; Martínez-Ramírez HR
    Am J Kidney Dis; 2008 May; 51(5):777-88. PubMed ID: 18436088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
    Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
    Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease.
    Bleyer AJ; Sedor JR; Freedman BI; O'Brien A; Russell GB; Graley J; Schelling JR
    Am J Kidney Dis; 2008 Jan; 51(1):29-37. PubMed ID: 18155530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of an educational strategy to improve family physicians' detection and management of depression: a randomized controlled trial.
    Worrall G; Angel J; Chaulk P; Clarke C; Robbins M
    CMAJ; 1999 Jul; 161(1):37-40. PubMed ID: 10420862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
    Perkins RM; Aboudara MC; Uy AL; Olson SW; Cushner HM; Yuan CM
    Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multifaceted education intervention for improving family physicians' case management.
    Reyes-Morales H; Flores-Hernández S; Tomé-Sandoval P; Pérez-Cuevas R
    Fam Med; 2009 Apr; 41(4):277-84. PubMed ID: 19343559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein restriction, glomerular filtration rate and albuminuria in patients with type 2 diabetes mellitus: a randomized trial.
    Pijls LT; de Vries H; van Eijk JT; Donker AJ
    Eur J Clin Nutr; 2002 Dec; 56(12):1200-7. PubMed ID: 12494305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal function.
    van den Meiracker AH; Baggen RG; Pauli S; Lindemans A; Vulto AG; Poldermans D; Boomsma F
    J Hypertens; 2006 Nov; 24(11):2285-92. PubMed ID: 17053552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How frequently the clinical practice recommendations for nephropathy are achieved in patients with type 2 diabetes mellitus in a primary health-care setting?
    Martínez-Ramírez HR; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Hernández M; Canales-Muñoz JL; Cueto-Manzano AM
    Rev Invest Clin; 2008; 60(3):217-26. PubMed ID: 18807734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of renal insufficiency in the diabetes TUV of the Deutsche BKK].
    Wolf G; Müller N; Tschauner T; Müller UA
    Med Klin (Munich); 2006 Jun; 101(6):441-7. PubMed ID: 16767567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of microalbuminuria by using losartan in normotensive patients with type 2 diabetes mellitus: A randomized controlled trial.
    Agha A; Amer W; Anwar E; Bashir K
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):429-35. PubMed ID: 19414946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the primary care physician in diagnosis and treatment of early renal damage.
    Cueto-Manzano AM; Cortés-Sanabria L; Martínez-Ramírez HR
    Ethn Dis; 2009; 19(1 Suppl 1):S1-68-72. PubMed ID: 19484880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of structured care by a pharmacist-diabetes specialist team in patients with type 2 diabetic nephropathy.
    Leung WY; So WY; Tong PC; Chan NN; Chan JC
    Am J Med; 2005 Dec; 118(12):1414. PubMed ID: 16378791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).
    Colhoun HM; Betteridge DJ; Durrington PN; Hitman GA; Neil HA; Livingstone SJ; Charlton-Menys V; DeMicco DA; Fuller JH;
    Am J Kidney Dis; 2009 Nov; 54(5):810-9. PubMed ID: 19540640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the impact of an evidence-based medicine educational intervention on primary care doctors' attitudes, knowledge and clinical behaviour: a controlled trial and before and after study.
    Shuval K; Berkovits E; Netzer D; Hekselman I; Linn S; Brezis M; Reis S
    J Eval Clin Pract; 2007 Aug; 13(4):581-98. PubMed ID: 17683300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.
    Lin SL; Chen YM; Chiang WC; Wu KD; Tsai TJ
    Am J Kidney Dis; 2008 Sep; 52(3):464-74. PubMed ID: 18617301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teleconferenced educational detailing: diabetes education for primary care physicians.
    Harris SB; Leiter LA; Webster-Bogaert S; Van DM; O'Neill C
    J Contin Educ Health Prof; 2005; 25(2):87-97. PubMed ID: 16078807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of a protocol-based strategy for achieving better blood pressure control in general practice.
    Godwin M; Birtwhistle R; Seguin R; Lam M; Casson I; Delva D; MacDonald S
    Fam Pract; 2010 Feb; 27(1):55-61. PubMed ID: 19887462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors for CKD in spouses and relatives of hemodialysis patients.
    Tsai JC; Chen SC; Hwang SJ; Chang JM; Lin MY; Chen HC
    Am J Kidney Dis; 2010 May; 55(5):856-66. PubMed ID: 20153917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.